View the latest contributions from our investment teams on the Australian investment landscape
By Tracey McNaugthon, Head of Investment Strategy
The Antipodean is designed to be a simple, thought-provoking piece on a market-relevant issue that is timely, topical and relevant for investment strategy. The article is written from an Australian perspective but will cover both domestic and international issues. A useful snapshot of key market and economic statistics will be updated with each new issue.
No More Practice Investment Series
Tracey McNaughton, features in the No More Practice Investment Series from evolution media group, where she showcases the benefits of the UBS Tactical Beta Funds. This CPD accredited initiative takes you behind the scenes, providing unprecedented access to the process of funds management and ratings. The show is supported by the ASX, FSC, Portfolio Construction Forum, leading research houses and one of Australia's largest independent platforms.
This website is intended for persons resident in Australia. UBS Global Asset Management (Australia) Ltd ABN 31 003 146 290, AFS Licence No. 222605 is the product issuer. Before making an investment decision, you need to consider whether this information is appropriate to your objectives, financial situation or needs. Any potential investor should consider the relevant PDS in deciding whether to acquire, or continue to hold units in a fund. Please consult your financial adviser. Past performance is not a reliable indicator of future performance.